...
首页> 外文期刊>Annals of Oncology >Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy
【24h】

Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy

机译:胸苷酸合酶,二氢嘧啶脱氢酶和胸苷磷酸化酶蛋白表达在以或不以5-氟尿嘧啶为基础的大肠癌患者中的预后意义

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Low tumour expression levels of thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD) and thymidine phosphorylase (TP) have been linked with improved outcome for colorectal cancer (CRC) patients treated with 5-fluorouracil (5-FU). It is unclear whether this occurs because such tumours have better prognosis or they are more sensitive to 5-FU treatment.
机译:背景:胸腺嘧啶合酶(TS),二氢嘧啶脱氢酶(DPD)和胸苷磷酸化酶(TP)的低肿瘤表达水平与5-氟尿嘧啶(5-FU)治疗的结直肠癌(CRC)患者的预后改善有关。目前尚不清楚是否发生这种情况,因为此类肿瘤的预后较好或对5-FU治疗更敏感。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号